POSTER: MM-533 Low-Dose Belantamab Mafodotin (Belamaf) in Combination With Nirogacestat Versus Belamaf Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 DREAMM-5 Platform Sub-Study 3
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
nirogacestat versus belamaf monotherapy,relapsed/refractory multiple myeloma,multiple myeloma,low-dose,sub-study
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要